Safety Study of Gene Therapy in Treating Critical Leg Ischemia

Clinical trial NCT00696124 · COMPLETED

Trial details

NCT number: NCT00696124
Sponsor: Helixmith Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2007-04-03
Primary completion: 2009-10-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.